Men at Higher Risk for AUR After BoNTA Treatment
Researchers in Taiwan have identified risk factors for adverse events (AEs) from intravesical injections of botulinum toxin A (BoNTA) for refractory idiopathic detrusor overactivity (IDO).
Diagnosis & Disease Information
Taking Responsiblity Found To Reduce Malpractice Suits
A recently published study in Annals of Internal Medicine (2010;153:213-221) shows that taking responsibility for medical errors and apologizing to patients leads to fewer lawsuits.
Nevada Supreme Court To Reexamine Damage Caps
Like Illinois and Georgia before it, the state Supreme Court of Nevada is being asked to decide whether limits on malpractice awards are constitutional.
Tennessee Considers Changes To Medical Malpractice Laws
The Tennessee legislature is considering two bills intended to reform medical malpractice claims.
Drug for Cushing’s Disease Shows Efficacy in Phase 3 Trial
An investigational drug called pasireotide is effective at reducing cortisol levels in patients with Cushing’s disease, according to the results of a phase 3 trial.
Gen-Probe Seeks Approval for Prostate Cancer Test
Gen-Probe has submitted a Premarket Approval Application (PMA) to the FDA for its PCA3 assay (Progensa), which may help determine the need for repeat prostate biopsies in men suspected of having prostate cancer.
Brand Name for Epoprostenol for Injection Okayed
The FDA has approved the brand name for commercially available Veletri (epoprostenol for injection) for pulmonary arterial hypertension (PAH).
Withdrawal of Approval for Midodrine Proposed
The FDA has proposed withdrawing approval of midodrine, a drug used to treat orthostatic hypotension, because required post-approval studies that verify the clinical benefit of the medication have not been done, the agency announced.
Drug for Chronic Refractory Gout Approved
Savient Pharmaceuticals, Inc., of East Brunswick, N.J., has received FDA clearance to market Krystexxa (pegloticase) as a treatment for chronic gout in adult patients refractory to conventional treatment.
Ureteral Stone Size Predictable, Data Show
The degree of hydronephrosis may predict ureteral stone size, according to a study published in the American Journal of Emergency Medicine (2010;28:813-816).
- Loading...
Loading...
Loading... 
Loading...